Modulation of Mitochondrial Membrane Potential and ROS Generation by Nicotinamide in a Manner Independent of SIRT1 and Mitophagy |
Song, Seon Beom
(Department of Life Science, University of Seoul)
Jang, So-Young (Department of Life Science, University of Seoul) Kang, Hyun Tae (Department of Life Science, University of Seoul) Wei, Bie (Department of Life Science, University of Seoul) Jeoun, Un-woo (Department of Biomedical Science and Department of Biochemistry, Ajou University School of Medicine) Yoon, Gye Soon (Department of Biomedical Science and Department of Biochemistry, Ajou University School of Medicine) Hwang, Eun Seong (Department of Life Science, University of Seoul) |
1 | Bernardi, P., Vassanelli, S., Veronese, P., Colonna, R., Szabo, I., and Zoratti, M. (1992). Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J. Biol. Chem. 267, 2934-2939. |
2 | Cheng, Y., Gulbins, E., and Siemen, D. (2011). Activation of the permeability transition pore by Bax via inhibition of the mitochondrial BK channel. Cell Physiol. Biochem. 27, 191-200. DOI |
3 | Choi, H.J., Jang, S.Y., and Hwang, E.S. (2015). High-dose nicotinamide suppresses ROS generation and augments population expansion during CD8(+) T cell activation. Mol. Cells 38, 918-924. DOI |
4 | Rennie, G., Chen, A.C., Dhillon, H., Vardy, J., and Damian, D.L. (2015). Nicotinamide and neurocognitive function. Nutr. Neurosci. 18, 193-200. DOI |
5 | Sakakibara, Y., Mitha, A.P., Ogilvy, C.S., Maynard, K.I. (2000). Posttreatment with nicotinamide (vitamin B(3)) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague-Dawley and wistar rats. Neurosci Lett. 281,111-114. DOI |
6 | Santidrian, A.F., LeBoeuf, S.E., Wold, E.D., Ritland, M., Forsyth, J.S., Felding, B.H. (2014). Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer. DNA Repair (Amst) 23, 79-87. DOI |
7 | Sasaki, T., Maier, B., Bartke, A., and Scrable, H. (2006). Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 5, 413-422. DOI |
8 | Saunders, L.R., Sharma, A.D., Tawney, J., Nakagawa, M., Okita, K., Yamanaka, S., Willenbring, H., and Verdin, E. (2010). miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) 2, 415-431. |
9 | Schneider, M.P., Delles, C., Schmidt, B.M., Oehmer, S., Schwarz, T.K., Schmieder, R.E., and John, S. (2005). Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension. Am. J. Hypertens. 18, 1111-1117. DOI |
10 | Chong, Z.Z., Lin, S.H., and Maiese, K. (2002). Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury. J. Vasc. Res. 39, 131-147. DOI |
11 | Crowley, C.L., Payne, C.M., Bernstein, H., Bernstein, C., and Roe, D. (2000). The NAD+ precursors, nicotinic acid and nicotinamide protect cells against apoptosis induced by a multiple stress inducer, deoxycholate. Cell Death Differ. 7, 314-326. DOI |
12 | Dengjel, J., and Abeliovich, H. (2017). Roles of mitophagy in cellular physiology and development. Cell Tissue Res. 367, 95-109. DOI |
13 | Du, H., and Yan, S.S. (2010). Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta. Biochim. Biophys. Acta. 1802, 198-204. DOI |
14 | Eiyama, A., and Okamoto, K. (2015). PINK1/Parkin-mediated mitophagy in mammalian cells. Curr. Opin. Cell Biol. 33, 95-101. DOI |
15 | Feldman, J.L., Dittenhafer-Reed, K.E., Kudo, N., Thelen, J.N., Ito, A., Yoshida, M., and Denu, J.M. (2015). Kinetic and structural basis for acyl-group selectivity and NAD(+) dependence in sirtuin-catalyzed deacylation. Biochemistry 54, 3037-3050. DOI |
16 | Stowe, D.F., and Camara, A.K. (2009). Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid. Redox. Signal.11, 1373-1414. DOI |
17 | Starkov, A.A., and Fiskum, G. (2003). Regulation of brain mitochondrial H2O2 production by membrane potential and NAD(P).H redox state. J. Neurochem. 86, 1101-1107. DOI |
18 | Rao, V.K., Carlson, E.A., and Yan, S.S. (2014). Mitochondrial permeability transition pore is a potential drug target for neurodegeneration. Biochim. Biophys. Acta. 1842, 1267-1272. DOI |
19 | Ghosh, D., LeVault, K.R., Barnett, A.J., and Brewer, G.J. (2012). A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons. J Neurosci. 32, 5821-5832. DOI |
20 | Stevens, M.J., Li, F., Drel, V.R., Abatan, O.I., Kim, H., Burnett, D., Larkin, D., and Obrosova, I.G. (2007). Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats. J. Pharmacol. Exp. Ther. 320, 458-464. |
21 | Thompson, A.M., Wagner, R., and Rzucidlo, E.M. (2014). Agerelated loss of SirT1 expression results in dysregulated human vascular smooth muscle cell function. Am. J. Physiol. Heart Circ. Physiol. 307, H533-541. DOI |
22 | Todisco, S., Agrimi, G., Castegna, A., and Palmieri, F. (2006). Identification of the mitochondrial NAD+ transporter in Saccharomyces cerevisiae. J. Biol. Chem. 281, 1524-1531. DOI |
23 | Twig, G., Elorza, A., Molina, A.J., Mohamed, H., Wikstrom, J.D., Walzer, G., Stiles, L., Haigh, S.E., Katz, S., Las, G., et al. (2008). Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27, 433-446. DOI |
24 | Huang, J.Y., Hirschey, M.D., Shimazu, T., Ho, L., and Verdin, E. (2010). Mitochondrial sirtuins. Biochim. Biophys. Acta. 1804, 1645-1651. DOI |
25 | Hafner, A.V., Dai, J., Gomes, A.P., Xiao, C.Y., Palmeira, C.M., Rosenzweig, A., and Sinclair, D.A. (2010). Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses agerelated cardiac hypertrophy. Aging (Albany NY). 2, 914-923. |
26 | Harlan, B.A., Pehar, M., Sharma, D.R., Beeson, G., Beeson, C.C., and Vargas, M.R. (2016). Enhancing NAD+ salvage pathway reverts the toxicity of primary astrocytes expressing amyotrophic lateral sclerosislinked mutant superoxide dismutase 1 (SOD1). J. Biol. Chem. 291, 10836-10846. DOI |
27 | Huang, J., Gan, Q., Han, L., Li, J., Zhang, H., Sun, Y., Zhang, Z., and Tong, T. (2008). SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS One 3, e1710. DOI |
28 | Hwang, E.S. and Song, S.B. (2017). Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells. Cell Mol. Life Sci. DOI 10.1007/s00018-017-2527-8. DOI |
29 | Hwang, E.S., Yoon, G., and Kang, H.T. (2009). A comparative analysis of the cell biology of senescence and aging. Cell Mol Life Sci. 66, 2503-2524. DOI |
30 | Jang, S.Y., Kang, H.T., and Hwang, E.S. (2012). Nicotinamideinduced mitophagy: event mediated by high NAD+/NADH ratio and SIRT1 protein activation. J. Biol. Chem. 287, 19304-19314. DOI |
31 | Yao, Y., Yang, Y., and Zhu, W.G. (2014). Sirtuins: nodes connecting aging, metabolism and tumorigenesis. Curr. Pharm. Des. 20, 1614-1624. DOI |
32 | Vercesi, A.E., Castilho, R.F., Meinicke, A.R., Valle, V.G., Hermes-Lima, M., and Bechara, E.J. (1994). Oxidative damage of mitochondria induced by 5-aminolevulinic acid: role of and membrane protein thiols. Biochim. Biophys. Acta 1188, 86-92. DOI |
33 | Villalba, J M., and Alcain, F.J. (2012). Sirtuin activators and inhibitors. Biofactors 38, 349-359. DOI |
34 | Yang, H., Yang, T., Baur, J. A., Perez, E., Matsui, T., Carmona, J.J., Lamming, D.W., Souza-Pinto, N.C., Bohr, V.A., Rosenzweig, A., et al. (2007). Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130, 1095-1107. DOI |
35 | Kiuchi, K., Yoshizawa, K., Shikata, N., Matsumura, M., Tsubura, A. (2002). Nicotinamide prevents N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in Sprague-Dawley rats and C57BL mice. Exp. Eye Res. 74, 383-392. DOI |
36 | Jendrach, M., Pohl, S., Voth, M., Kowald, A., Hammerstein, P., and Bereiter-Hahn, J. (2005). Morpho-dynamic changes of mitochondria during ageing of human endothelial cells. Mech. Ageing Dev. 126, 813-821. DOI |
37 | Kaneko S., Wang J., Kaneko M., Yiu G., Hurrell J.M., Chitnis T., Khoury S.J., and He Z. (2006). Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J. Neurosci. 26, 9794-9804. DOI |
38 | Kang, H.T., and Hwang, E.S. (2009). Nicotinamide enhances mitochondria quality through autophagy activation in human cells. Aging Cell 8, 426-438. DOI |
39 | Kang, H.T., Lee, H.I., and Hwang, E.S. (2006). Nicotinamide extends replicative lifespan of human cells. Aging Cell 5, 423-436. DOI |
40 | Kim, I., Rodriguez-Enriquez, S., and Lemasters, J.J. (2007). Selective degradation of mitochondria by mitophagy. Arch. Biochem. Biophys. 462, 245-253. DOI |
41 | Klaidman, L.K., Mukherjee, S.K., and Adams, J.D., Jr. (2001). Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim. Biophys. Acta. 1525, 136-148. DOI |
42 | Kushnareva, Y., Murphy, A. N., and Andreyev, A. (2002). Complex Imediated reactive oxygen species generation: modulation by cytochrome c and NAD(P).+ oxidation-reduction state. Biochem. J. 368, 545-553. DOI |
43 | Lee, H.C., Yin, P.H., Chi, C.W., and Wei, Y.H. (2002). Increase in mitochondrial mass in human fibroblasts under oxidative stress and during replicative cell senescence. J. Biomed. Sci. 9, 517-526. DOI |
44 | Leung, A.W., and Halestrap, A.P. (2008). Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim. Biophys. Acta 1777, 946-952. DOI |
45 | Lee, E.J., Wu, T.S., Chang, G.L., Li, C.Y., Chen, T.Y., Lee, M.Y., Chen, H.Y., and Maynard, K.I. (2006). Delayed treatment with nicotinamide inhibits brain energy depletion, improves cerebral microperfusion, reduces brain infarct volume, but does not alter neurobehavioral outcome following permanent focal cerebral ischemia in Sprague Dawley rats. Curr. Neurovasc. Res. 3, 203-213. DOI |
46 | Lee, H.I., Jang, S.Y., Kang, H.T., and Hwang, E.S. (2008). p53-, SIRT1-, and PARP-1-independent downregulation of p21WAF1 expression in nicotinamide-treated cells. Biochem. Biophys. Res. Commun. 368, 298-304. DOI |
47 | Lee, I.H., Cao, L., Mostoslavsky, R., Lombard, D.B., Liu, J., Bruns, N.E., Tsokos, M., Alt, F.W., and Finkel, T. (2008). A role for the NADdependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. USA 105, 3374-3379. DOI |
48 | Li, F., Chong, Z.Z., and Maiese, K. (2004). Navigating novel mechanisms of cellular plasticity with the NAD+ precursor and nutrient nicotinamide. Front. Biosci. 9, 2500-2520. DOI |
49 | Machida, K. and Osada, H. (2003). Molecular interaction between cyclophilin D and adenine nucleotide translocase in cytochrome c release: does it determine whether cytochrome c release is dependent on permeability transition or not? Ann. N Y Acad. Sci. 1010, 182-185 DOI |
50 | Maiese, K., Chong, Z.Z., Hou, J., Shang, Y.C. (2009). The vitamin nicotinamide: translating nutrition into clinical care. Molecules 14, 3446-3485. DOI |
51 | Murray, M.F. (2003). Nicotinamide: an oral antimicrobial agent with activity against both Mycobacterium tuberculosis and human immunodeficiency virus. Clin. Infect Dis. 36, 453-460. DOI |
52 | Zhang, J., Fitsanakis, V.A., Gu, G., Jing, D., Ao, M., Amarnath, V., and Montine, T.J. (2003). Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J. Neurochem. 84, 336-346. DOI |
53 | Zorov, D.B., Juhaszova, M., and Sollott, S.J. (2014). Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 94, 909-950. DOI |
54 | Ayoub, I.A., and Maynard, K.I. (2002). Therapeutic window for nicotinamide following transient focal cerebral ischemia. Neuroreport 13, 213-216. DOI |
55 | Matsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C.A., Sou, Y.S., Saiki, S., Kawajiri, S., Sato, F., et al. (2010). PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J. Cell Biol. 189, 211-221. DOI |
56 | Menzies, K.J., and Hood, D.A. (2012). The role of SirT1 in muscle mitochondrial turnover. Mitochondrion 12, 5-13. DOI |
57 | Milne, J.C., Lambert, P.D., Schenk, S., Carney, D.P., Smith, J.J., Gagne, D.J., Jin, L., Boss, O., Perni, R.B., Vu, C.B., et al. (2007). Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716. DOI |
58 | Murphy, M.P. (2009). How mitochondria produce reactive oxygen species. Biochem. J. 417, 1-13. DOI |
59 | Narendra, D., Tanaka, A., Suen, D.F., and Youle, R.J. (2008). Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795-803. DOI |
60 | Oblong, J.E. (2014). The evolving role of the NAD+/nicotinamide metabolome in skin homeostasis, cellular bioenergetics, and aging. DNA Repair (Amst). 23, 59-63. DOI |
61 | Olmos, Y., Sanchez-Gomez, F.J., Wild, B., Garcia-Quintans, N., Cabezudo, S., Lamas, S., and Monsalve, M. (2013). SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a/PGC 1alpha complex. Antioxid Redox Signa. 19, 1507-1521. DOI |
62 | Petronilli, V., Miotto, G., Canton, M., Colonna, R., Bernardi, P., and Di Lisa, F. (1998). Imaging the mitochondrial permeability transition pore in intact cells. Biofactors 8, 263-272. DOI |
63 | Bayrakdar, E.T., Armagan, G., Uyanikgil, Y., Kanit, L., Koylu, E., and Yalcin, A. (2014). Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Abeta(1-42). Cell Biochem. Funct. 32, 557-564. DOI |